Trial Outcomes & Findings for Opiate Sparing Versus Opiate Based Following Shoulder Arthroplasty (NCT NCT04294680)

NCT ID: NCT04294680

Last Updated: 2022-12-06

Results Overview

The Visual Analog Score (VAS) is a a validated patient reported pain score with possible range from zero (no pain) to ten (worst possible pain).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

82 participants

Primary outcome timeframe

postoperative day fourteen (two weeks)

Results posted on

2022-12-06

Participant Flow

Participant milestones

Participant milestones
Measure
Opiate Sparing
Cryotherapy one hour daily four times per day for two weeks postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeproazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative Oxycodone 5 milligrams every six hours by mouth as needed for uncontrolled pain for fourteen days postoperative Cryotherapy: see opiate sparing description
Opiate Based
Oxycodone 5 to 10 milligrams every four to six hours by mouth as needed for pain for fourteen days postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeprazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative
Overall Study
STARTED
39
43
Overall Study
Received Allocated Intervention
37
42
Overall Study
COMPLETED
36
42
Overall Study
NOT COMPLETED
3
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Opiate Sparing
Cryotherapy one hour daily four times per day for two weeks postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeproazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative Oxycodone 5 milligrams every six hours by mouth as needed for uncontrolled pain for fourteen days postoperative Cryotherapy: see opiate sparing description
Opiate Based
Oxycodone 5 to 10 milligrams every four to six hours by mouth as needed for pain for fourteen days postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeprazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative
Overall Study
Withdrawal by Subject
2
1
Overall Study
Follow-up visits completed outside of window
1
0

Baseline Characteristics

Opiate Sparing Versus Opiate Based Following Shoulder Arthroplasty

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Opiate Sparing
n=36 Participants
Cryotherapy one hour daily four times per day for two weeks postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeproazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative Oxycodone 5 milligrams every six hours by mouth as needed for uncontrolled pain for fourteen days postoperative Cryotherapy: see opiate sparing description
Opiate Based
n=42 Participants
Oxycodone 5 to 10 milligrams every four to six hours by mouth as needed for pain for fourteen days postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeprazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative
Total
n=78 Participants
Total of all reporting groups
Age, Continuous
72.1 years
STANDARD_DEVIATION 6.6 • n=99 Participants
72.4 years
STANDARD_DEVIATION 5.4 • n=107 Participants
72.24 years
STANDARD_DEVIATION 5.9 • n=206 Participants
Sex: Female, Male
Female
16 Participants
n=99 Participants
15 Participants
n=107 Participants
31 Participants
n=206 Participants
Sex: Female, Male
Male
20 Participants
n=99 Participants
27 Participants
n=107 Participants
47 Participants
n=206 Participants
Race/Ethnicity, Customized
White Race
34 Participants
n=99 Participants
40 Participants
n=107 Participants
74 Participants
n=206 Participants
Race/Ethnicity, Customized
Other Race
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Body Mass Index
30.5 kg/m^2
STANDARD_DEVIATION 4.1 • n=99 Participants
30.2 kg/m^2
STANDARD_DEVIATION 6.3 • n=107 Participants
30.36 kg/m^2
STANDARD_DEVIATION 5.4 • n=206 Participants

PRIMARY outcome

Timeframe: postoperative day fourteen (two weeks)

Population: All patients that completed surgery, received their assigned intervention, and completed all follow-up visits within the study window

The Visual Analog Score (VAS) is a a validated patient reported pain score with possible range from zero (no pain) to ten (worst possible pain).

Outcome measures

Outcome measures
Measure
Opiate Sparing
n=36 Participants
Cryotherapy one hour daily four times per day for two weeks postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeproazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative Oxycodone 5 milligrams every six hours by mouth as needed for uncontrolled pain for fourteen days postoperative Cryotherapy: see opiate sparing description
Opiate Based
n=42 Participants
Oxycodone 5 to 10 milligrams every four to six hours by mouth as needed for pain for fourteen days postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeprazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative
Visual Analog Score (VAS) at Week 2
1.4 score on a scale
Standard Deviation 1.7
1.8 score on a scale
Standard Deviation 2.3

SECONDARY outcome

Timeframe: Post-operative Day 1 through 12 weeks

Population: All patients that completed surgery, received their assigned intervention, and completed all follow-up visits within the study window.

The total number of opioid pain pills consumed from post-operative day 1 to Week 12

Outcome measures

Outcome measures
Measure
Opiate Sparing
n=36 Participants
Cryotherapy one hour daily four times per day for two weeks postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeproazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative Oxycodone 5 milligrams every six hours by mouth as needed for uncontrolled pain for fourteen days postoperative Cryotherapy: see opiate sparing description
Opiate Based
n=42 Participants
Oxycodone 5 to 10 milligrams every four to six hours by mouth as needed for pain for fourteen days postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeprazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative
Number of Opioid Pain Pills Taken
4.3 opioid pain pills
Standard Deviation 11.9
17.0 opioid pain pills
Standard Deviation 19.6

Adverse Events

Opiate Sparing

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Opiate Based

Serious events: 0 serious events
Other events: 1 other events
Deaths: 1 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Opiate Sparing
n=36 participants at risk
Cryotherapy one hour daily four times per day for two weeks postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeproazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative Oxycodone 5 milligrams every six hours by mouth as needed for uncontrolled pain for fourteen days postoperative Cryotherapy: see opiate sparing description
Opiate Based
n=42 participants at risk
Oxycodone 5 to 10 milligrams every four to six hours by mouth as needed for pain for fourteen days postoperative Acetaminophen 1000 milligrams every six hours by mouth for fourteen days postoperative Gabapentin 100 milligrams three times per day by mouth for thirty days postoperative Celecoxib 100 milligrams two times per day by mouth for thirty days postoperative Esomeprazole 20 milligrams daily by mouth for thirty days postoperative Ondansetron 4 milligrams every eight hours by mouth as needed for nausea and/or vomiting for fourteen days postoperative
Musculoskeletal and connective tissue disorders
Periprosthetic Fracture
2.8%
1/36 • Adverse events, postoperative complications, readmissions, and reoperations were recorded from day of surgery through week 12
2.4%
1/42 • Adverse events, postoperative complications, readmissions, and reoperations were recorded from day of surgery through week 12
Musculoskeletal and connective tissue disorders
Acromial Stress Fracture
2.8%
1/36 • Adverse events, postoperative complications, readmissions, and reoperations were recorded from day of surgery through week 12
0.00%
0/42 • Adverse events, postoperative complications, readmissions, and reoperations were recorded from day of surgery through week 12

Additional Information

Principal Investigator

Campbell Clinic

Phone: 9017595522

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place